Truvada
Gilead’s Truvada becomes first China-approved drug to prevent HIV-1
August 13, 2020Sales and Marketing China, Truvada, approval. HIV
China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …
Gilead challenges Government over patents on preventative HIV drug Truvada
August 22, 2019Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents
Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …
Gilead CEO Daniel O’Day challenged over patents on PrEP drug Truvada
May 17, 2019Medical Communications Gilead, HIV, PrEP, Truvada, patent, pharma
On 16 May, Gilead CEO Daniel O’Day was grilled over the $1,780 price tag on PrEP drug Truvada in a …
Gilead will give 11 years’ worth of PrEP drugs to those at risk of HIV after ‘discussions’ with Trump
May 10, 2019Medical Communications Gilead, HIV, PrEP, Trump, Truvada, descovy
Gilead Sciences has agreed to donate 11 years’ worth PrEP drugs for up to 200,000 individuals each year, following “discussions …
Gilead accused of ripping off US taxpayers
March 28, 2019Medical Communications, Sales and Marketing CDC, Gilead, HIV, PrEP, Truvada, US government, patents
Gilead have been accused of ‘ripping off’ US taxpayers after the firm was revealed to have generated $3 billion in …
AIDS charity lambasts “ethically challenged” Gilead over price hikes
January 11, 2018Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …
Anti-HIV drug PrEP proves safety in gay and bisexual adolescents
September 6, 2017Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma
A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …
HIV-preventing drug to be trialed across England
August 7, 2017Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …
Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland
July 6, 2017Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada
Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …
Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court
A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
Gilead gets EU approval for HIV-prevention treatment Truvada
August 23, 2016Manufacturing and Production, Sales and Marketing EU, Gilead, HIV, PrEP, Truvada, prevention
Gilead Sciences has received marketing authorisation from the European Commission for once-daily Truvada (emtricitabine/tenofovir disoproxil), in combination with safer sex …
Gilead’s Truvada prevents HIV infections in high-risk men
September 10, 2015Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections
UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
